Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
The Lancet. Psychiatry|September 12, 2015
Clinical management of comorbid diabetes and psychotic disordersLydia A Chwastiak, Oliver Freudenreich, Cenk Tek, et al.
Translational Psychiatry|October 27, 2020
Decreased mitochondrial electron transport proteins and increased complement mediators in plasma neural-derived exosomes of early psychosisEdward J Goetzl, Vinod H Srihari, Sinan Guloksuz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 17, 2021
Neural cell-derived plasma exosome protein abnormalities implicate mitochondrial impairment in first episodes of psychosisEdward J Goetzl, Vinod H Srihari, Sinan Guloksuz, et al.
Comprehensive Psychiatry|March 20, 2012
The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional studyJoseph C Ratliff, Laura B Palmese, Erin L Reutenauer, et al.
Comprehensive Psychiatry|September 11, 2012
Prevalence of night eating in obese individuals with schizophrenia and schizoaffective disorderLaura B Palmese, Joseph C Ratliff, Erin L Reutenauer, et al.
Community Mental Health Journal|January 12, 2013
Reliability and practicality of measuring waist circumference to monitor cardiovascular risk among community mental health center patientsJessica Barber, Laura Palmese, Lydia A Chwastiak, et al.
Schizophrenia Bulletin|June 6, 2019
Antipsychotic Exposure in Pregnancy and the Risk of Gestational Diabetes: A Systematic Review and Meta-analysisSuat Kucukgoncu, Sinan Guloksuz, Kubra Celik, et al.
Schizophrenia Research|January 19, 2011
Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?Vivek H Phutane, Cenk Tek, Lydia Chwastiak, et al.
Schizophrenia Research|February 21, 2013
Cardiovascular mortality in schizophrenia: defining a critical period for preventionVinod H Srihari, Vivek H Phutane, Banu Ozkan, et al.
Schizophrenia Research|December 3, 2014
The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trialCenk Tek, Laura B Palmese, Andrew D Krystal, et al.
Pageof 7